Association of the FGA and SLC6A4 genes with autistic spectrum disorder in a korean population

Neuropsychobiology

Volumn 68, Issue 4, 2013, Pages 212-220

  Ro, Myungja ^a   Won, Seongsik ^a   Kang, Hyunjun ^a   Kim, Su Yeon ^a   Lee, Seung Ku ^a   Nam, Min ^b   Bang, Hee Jung ^c   Yang, Jae Won ^e   Choi, Kyung Sik ^f   Kim, Su Kang ^d   Chung, Joo Ho ^d   Kwack, Kyubum ^a  

^a CHA University   (South Korea)

^b Seoul Metropolitan Children's Hospital   (South Korea)

^c Ewha Womans University   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Joongbu University   (South Korea)

Author keywords

Autism spectrum disorder; Childhood Autism Rating Scale; FGA; Polymorphism; SLC6A4

Indexed keywords

FIBRINOGEN; FIBRINOGEN ALPHA CHAIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASPERGER SYNDROME; AUTISM; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CHILDHOOD AUTISM RATING SCALE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; INCIDENCE; KOREAN (PEOPLE); LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL (TOPIC); PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTISTIC DISORDER; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84886734370     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000355299     Document Type: Article

References (39)

1. Costa e Silva JA: Autism, a brain developmental disorder: Some new pathopysiologic and genetics findings. Metabolism 2008; 57(suppl 2):S40-S43.
2. Faras H, Al Ateeqi N, Tidmarsh L: Autism spectrum disorders. Ann Saudi Med 2010; 30: 295-300.
3. Folstein S, Rutter M: Infantile autism: A genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977; 18: 297-321.
4. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M: Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 1995; 25: 63-77.
5. Taniai H, Nishiyama T, Miyachi T, Imaeda M, Sumi S: Genetic influences on the broad spectrum of autism: Study of proband-ascertained twins. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:844-849.
6. Anney R, Klei L, Pinto D, et al: Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet 2012; 21: 4781-4792.
7. Weiss LA, Arking DE, Daly MJ, Chakravarti A: A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009; 461: 802-808.
8. Casey JP, Magalhaes T, Conroy JM, et al: A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet 2012; 131: 565-579.
9. Ben-David E, Shifman S: Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLoS Genet 2012; 8:e1002556.
10. Sodhi MS, Sanders-Bush E: Serotonin and brain development. Int Rev Neurobiol 2004; 59: 111-174.
11. Gingrich JA, Hen R: Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 2001; 155: 1-10.
12. Anderson GM: Genetics of childhood disorders: XlV-autism. 4. Serotonin in autism. J Am Acad Child Adolesc Psychiatry 2002; 41: 1513-1516.
13. Zafeiriou DI, Ververi A, Vargiami E: The serotonergic system: Its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 2009; 7: 150-157.
14. Whitaker-Azmitia PM: Behavioral and cellular consequences of increasing serotonergic activity during brain development: A role in autism? Int J Dev Neurosci 2005; 23: 75-83.
15. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, Folstein SE, Haines JL, Sutcliffe JS: Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 2004; 127B:104-112.
16. Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, Haas R, Courchesne E, Leventhal BL: Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2: 247-250.
17. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD: Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 2005; 77: 265-279.
18. Holmes A, Lit Q, Murphy DL, Gold E, Crawley JN: Abnormal anxiety-related behavior in serotonin transporter null mutant mice: The influence of genetic background. Genes Brain Behav 2003; 2: 365-380.
19. Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, Marques C, Ataide A, Miguel T, Borges L, Vicente AM: Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004; 9: 264-271.
20. Cho IH, Yoo HJ, Park M, Lee YS, Kim SA: Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res 2007; 1139: 34-41.
21. Carneiro AM, Cook EH, Murphy DL, Blakely RD: Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 2008; 118: 1544-1552.
22. Rivas G, Tangemann K, Minton AP, Engel J: Binding of fibrinogen to platelet integrin alpha IIb beta 3 in solution as monitored by tracer sedimentation equilibrium. J Mol Recognit 1996; 9: 31-38.
23. Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, Greven S, Salomaa V, Sunyer J, Bellander T, Chalamandaris AG, Pistelli R, Koenig W, Peters A: Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: The AIRGENE study. J Am Coll Cardiol 2008; 52: 941-952.
24. Wu S, Guo Y, Jia M, Ruan Y, Shuang M, Liu J, Gong X, Zhang Y, Yang J, Yang X, Zhang D: Lack of evidence for association between the serotonin transporter gene (SLC6A4) polymorphisms and autism in the Chinese trios. Neurosci Lett 2005; 381: 1-5.
25. Seneviratne C, Huang W, Ait-Daoud N, Li MD, Johnson BA: Characterization of a functional polymorphism in the 3 ? UTR of SLC6A4 and its association with drinking intensity. Alcohol Clin Exp Res 2009; 33: 332-339.
26. Wray NR, James MR, Gordon SD, Dumenil T, Ryan L, Coventry WL, Statham DJ, Pergadia ML, Madden PA, Heath AC, Montgomery GW, Martin NG: Accurate, large-scale genotyping of 5 HTTLPR and flanking single nucleotide polymorphisms in an association study of depression, anxiety, and personality measures. Biol Psychiatry 2009; 66: 468-476.
27. Folstein SE, Rosen-Sheidley B: Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001; 2: 943-955.
28. Mulder EJ, Anderson GM, Kema IP, De Bildt A, Van Lang ND, Den Boer JA, Minderaa RB: Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry 2004; 43: 491-499.
29. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD: Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci USA 2012; 109: 5469-5474.
30. Yoo HJ, Cho IH, Park M, Yang SY, Kim SA: No association study of SLC6A4 polymorphisms with Korean autism spectrum disorder. Korean J Biol Psychiatry 2009; 16: 121-126.
31. Su S, Zhao J, Bremner JD, Miller AH, Tang W, Bouzyk M, Snieder H, Novik O, Afzal N, Goldberg J, Vaccarino V: Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet 2009; 2: 614-620.
32. Mannila MN, Eriksson P, Leander K, Wiman B, De Faire U, Hamsten A, Silveira A: The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. J Int Med 2007; 261: 138-147.
33. Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Juhasz G, Bagdy G: New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry 2008; 64: 498-504.
34. Weiss LA, Ober C, Cook EH Jr: ITGB3 shows genetic and expression interaction with SLC6A4. Hum Genet 2006; 120: 93-100.
35. Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, Marques C, Ataide A, Miguel TS, Moore JH, Oliveira G, Vicente AM: Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 2007; 121: 243-256.
36. Ellis SJ, Tanentzapf G: Integrin-mediated adhesion and stem-cell-niche interactions. Cell Tissue Res 2010; 339: 121-130.
37. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Rumley A, Lowe GD, Fowkes FG: Cognitive decline and markers of inflammation and hemostasis: The Edinburgh Artery Study. J Am Geriatr Soc 2007; 55: 700-707.
38. Marioni RE, Deary IJ, Murray GD, Lowe GD, Strachan MW, Luciano M, Houlihan LM, Gow AJ, Harris SE, Rumley A, Stewart MC, Fowkes FG, Price JF: Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts. Behav Genet 2011; 41: 691-699.
39. Cohen J: Statistical Power Analysis for the Behavioral Sciencies, ed 2. Hillsdale, Erlbaum, 1988.